Table 1. Correlation of miR-23a expression in tissues with clinicopathological variables of patients in 123 cases of prostate cancer.
| Variables | miR-23a | p Value | ||
|---|---|---|---|---|
| All cases (n = 123) | Low expression (n = 62) | High expression (n = 61) | ||
| Age(years) | ||||
| ≤ 68.5 | 66 | 32 (48.5) | 34 (51.5) | 0.646 |
| > 68.5 | 57 | 30 (52.6) | 27 (47.4) | |
| PSA level (μg/L) | ||||
| ≤ 10 | 64 | 23 (35.9) | 41 (64.1) | 0.001 |
| > 10 | 59 | 39 (66.1) | 20 (33.9) | |
| gleason | ||||
| ≤ 7 | 93 | 42 (45.2) | 51 (54.8) | 0.041 |
| > 7 | 30 | 20 (66.7) | 10 (33.3) | |
| Distant metastasis | ||||
| M0 | 111 | 52 (46.8) | 59 (53.2) | 0.016 |
| M1 | 12 | 10 (83.3) | 2 (16.7) | |
| Pathologic stage | ||||
| ≤ T2 | 90 | 39 (43.3) | 51 (56.7) | 0.010 |
| > T2 | 33 | 23 (69.7) | 10 (30.3) | |